Business programme

Regulation of the Pharmaceutical Market: Law in Search of a Balance

Congress Centre, conference hall D4
Law, Business, and Sanctions
Access to medication is a crucial aspect of public health, maintaining quality of life for patients, etc. And it is essential to ensure both availability and affordability. A range of legal tools have been employed to these ends. These include protecting intellectual property rights, price regulation for certain items, incentives for participating in government procurement schemes, and so on. The key legal issue in this regard is striking the right balance between the interests of various players in the market, while doing everything possible to meet societal needs.
• Ensuring access to medication: striking a balance between protecting intellectual property rights and meeting societal needs.
• Employing antimonopoly regulation as part of efforts to ensure availability of medication (registration of prices for vital and essential medicines, unscheduled inspections of business entities, amendments to rules underpinning government procurement procedures).


Konstantin Sharlovsky
Head of Pharmaceuticals and Healthcare Practice, Pepeliaev Group


Sergey Glagolev
Deputy Minister of Health of the Russian Federation (online)
Ivan Glushkov
Chief Executive Officer, PharmCapital
Timofey Nizhegorodtsev
Deputy Head, Federal Antimonopoly Service of the Russian Federation
Ajay Manikrao Khanwilkar
Judge, Supreme Court of the Republic of India
Fatima Tsomartova
Senior Researcher, Institute of Legislation and Comparative Law under the Government of the Russian Federation
Tadzio Schilling
Chief Executive Officer, Association of European Businesses (АЕВ)